Influential Factors when Making Decisions About Dementia Medications in Memory Assessment Services; a Focused...

Area of Science:

• Gerontology
• Pharmacology
• Communication Studies

Background:

• Discussing dementia medications is complex due to disease variability, limited curative options, and communication barriers.
• Shared decision-making in dementia care is often restricted.
• This study investigates communication dynamics surrounding dementia pharmacotherapy in clinical practice.

Purpose of the Study:

• To examine how dementia medications are discussed in clinical settings.
• To understand the factors influencing decision-making regarding dementia pharmacotherapy.
• To identify communication strategies and information needs in dementia medication discussions.

Main Methods:

• Utilized focused video/audio ethnography of 14 clinical appointments.
• Conducted semi-structured interviews with 23 patients/supporters and 5 clinicians.
• Employed qualitative methods to analyze communication practices and decision-making processes.

Main Results:

• Identified themes of "Framing and understanding of information in the context of uncertainty" and "'Not worth the risk' or 'nothing to lose'."
• Risk perception significantly influenced decision-making, especially for vulnerable patients, when benefits were uncertain.
• Clinicians' framing of information, often based on experience, impacts patient and supporter choices.

Conclusions:

• Clinicians must recognize their influence and the framing of their opinions in patient decision-making.
• Standardized information sources are needed for clinicians to universally convey medication benefits and side effects.
• Accessible information for patients and relatives is crucial for informed decisions amidst uncertainty regarding dementia pharmacotherapy.